Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 2
1990 4
1993 4
1994 1
1995 1
1996 2
1997 3
1998 5
1999 3
2000 5
2001 2
2002 1
2003 1
2005 2
2006 1
2008 2
2009 3
2010 1
2011 2
2012 2
2013 1
2014 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Serotonin 5-HT3 and 5-HT4 receptor antagonists.
Gaster LM, King FD. Gaster LM, et al. Among authors: king fd. Med Res Rev. 1997 Mar;17(2):163-214. doi: 10.1002/(sici)1098-1128(199703)17:2<163::aid-med2>;2-y. Med Res Rev. 1997. PMID: 9057164 Review. No abstract available.
Azabicyclic indole esters as potent 5-HT4 receptor antagonists.
Wyman PA, Gaster LM, King FD, Sutton JM, Ellis ES, Wardle KA, Young TJ. Wyman PA, et al. Among authors: king fd. Bioorg Med Chem. 1996 Feb;4(2):255-61. doi: 10.1016/0968-0896(96)00037-5. Bioorg Med Chem. 1996. PMID: 8814883
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).
Bromidge SM, Clarke SE, Gager T, Griffith K, Jeffrey P, Jennings AJ, Joiner GF, King FD, Lovell PJ, Moss SF, Newman H, Riley G, Rogers D, Routledge C, Serafinowska H, Smith DR. Bromidge SM, et al. Among authors: king fd. Bioorg Med Chem Lett. 2001 Jan 8;11(1):55-8. doi: 10.1016/s0960-894x(00)00597-7. Bioorg Med Chem Lett. 2001. PMID: 11140733
The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.
Takle AK, Bamford MJ, Davies S, Davis RP, Dean DK, Gaiba A, Irving EA, King FD, Naylor A, Parr CA, Ray AM, Reith AD, Smith BB, Staton PC, Steadman JG, Stean TO, Wilson DM. Takle AK, et al. Among authors: king fd. Bioorg Med Chem Lett. 2008 Aug 1;18(15):4373-6. doi: 10.1016/j.bmcl.2008.06.070. Epub 2008 Jun 24. Bioorg Med Chem Lett. 2008. PMID: 18621524
The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.
Takle AK, Brown MJ, Davies S, Dean DK, Francis G, Gaiba A, Hird AW, King FD, Lovell PJ, Naylor A, Reith AD, Steadman JG, Wilson DM. Takle AK, et al. Among authors: king fd. Bioorg Med Chem Lett. 2006 Jan 15;16(2):378-81. doi: 10.1016/j.bmcl.2005.09.072. Epub 2005 Nov 2. Bioorg Med Chem Lett. 2006. PMID: 16260133
A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).
Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR. Lovell PJ, et al. Among authors: king fd. J Med Chem. 2000 Feb 10;43(3):342-5. doi: 10.1021/jm991151j. J Med Chem. 2000. PMID: 10669560 No abstract available.
48 results